Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

10.10 +0.32 (+3.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,063,140
Open 9.600
Bid (Size) 9.900 (100)
Ask (Size) 10.20 (400)
Prev. Close 9.780
Today's Range 9.600 - 10.28
52wk Range 4.720 - 19.11
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call
NeoGenomics’ third quarter results were met with a negative market reaction, as shares declined following the announcement. Management attributed the quarter’s performance to robust growth in clinical... 
Via StockStory
Topics Earnings
NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?
NeoGenomics trades at $9.78 per share and has stayed right on track with the overall market, gaining 24.7% over the last six months. At the same time, the S&P 500 has returned 21.3%. 
Via StockStory
Topics Stocks

Performance

YTD
-38.8%
-38.8%
1 Month
+11.0%
+11.0%
3 Month
+78.1%
+78.1%
6 Month
+28.8%
+28.8%
1 Year
-28.6%
-28.6%

More News

Read More
NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
Via StockStory
Earnings Scheduled For October 28, 2025
Via Benzinga
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics (NEO) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Intellectual Property
Why NeoGenomics (NEO) Stock Is Trading Up Today
Via StockStory
Topics World Trade
NeoGenomics Inc (NASDAQ:NEO) Surpasses Q3 Revenue Estimates as Clinical Testing Drives Growth
Via Chartmill
Topics Earnings
NeoGenomics’s (NASDAQ:NEO) Q3 Sales Top Estimates, Stock Soars
Via StockStory
NeoGenomics Reports Third Quarter 2025 Results
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics (NEO) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence
3 Healthcare Stocks Walking a Fine Line
Via StockStory
Topics Stocks
3 Unprofitable Stocks with Open Questions
Via StockStory
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
From NeoGenomics, Inc.
Via Business Wire
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
From NeoGenomics, Inc.
Via Business Wire
3 Russell 2000 Stocks We Approach with Caution
Via StockStory
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
Via StockStory
Topics World Trade
3 Cash-Burning Stocks We’re Skeptical Of
Via StockStory
NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026
Via Benzinga
Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
From Pomerantz LLP
Via GlobeNewswire
1 Safe-and-Steady Stock Worth Your Attention and 2 We Ignore
Via StockStory
Why NeoGenomics (NEO) Shares Are Falling Today
Via StockStory
Topics Intellectual Property Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 10.10
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 11/04/25 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.24B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.